Table 3.
Variable | (A) Progressive Disease | (B) Controlled Disease | ||||
---|---|---|---|---|---|---|
OR | CI 95% | p = | OR | CI 95% | p = | |
Age | 0.992 | 0.964–1.021 | 0.581 | 1.003 | 0.973–1.034 | 0.831 |
Gender | 0.670 | 0.245–1.824 | 0.433 | 0.543 | 0.180–1.633 | 0.277 |
P—Localisation of parasite | 1.886 | 0.824–4.313 | 0.133 | 0.668 | 0.335–1.330 | 0.251 |
N—Involvement of neighbouring organs | 3.696 | 1.173–11.653 | 0.026 | 0.616 | 0.113–3.347 | 0.575 |
Staging (I–IV) * | 2.860 | 1.384–5.911 | 0.005 | 0.670 | 0.389–1.154 | 0.149 |
Largest diameter of lesion | 1.017 | 1.004–1.029 | 0.007 | 0.972 | 0.949–0.996 | 0.022 |
Morphology of lesion | 0.979 | 0.848–1.132 | 0.778 | 1.029 | 0.933–1.134 | 0.571 |
IgE levels at first presentation | 1.000 | 1.000–1.000 | 0.822 | 1.000 | 0.998–1.001 | 0.594 |
Echinococcus IgG EIA | 1.007 | 0.998–1.015 | 0.131 | 0.997 | 0.979–1.014 | 0.704 |
Echinococcus Em2+ ELISA | 1.611 | 0.174–14.925 | 0.675 | 0.245 | 0.072–0.835 | 0.024 |
γGT at first presentation | 1.000 | 0.998–1.002 | 0.733 | 0.998 | 0.992–1.004 | 0.587 |
OR = odds ratio, CI 95% = 95% confidence interval, p = significance level with significant results printed bold. * If staging was included in the model, ‘P’ and ‘N’ were excluded. Size remained significant with p = 0.008.